Label: VITAMIN B COMPLEX 150- vitamin b complex injection
- NDC Code(s): 59051-9085-5
- Packager: Neogen Corporation - Nandino
- Category: PRESCRIPTION ANIMAL DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated December 18, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Indications:
-
Each mL Contains:
Thiamine Hydrochloride..................................................150 mg
Riboflavin 5' Sodium Phosphate USP....................................2 mg
Niacinamide..................................................................150 mg
d-Panthenol....................................................................10 mg
Pyridoxine HCL................................................................10 mg
Inositol..........................................................................20 mg
Choline Chloride..............................................................20 mg
Benzyl Alcohol (preservative)...........................................2% v/v
Water for Injection...............................................................q.s.
- Dosage and Administration:
- Warning:
- STORAGE AND HANDLING
- SPL UNCLASSIFIED SECTION
- SPL UNCLASSIFIED SECTION
- Principal Display Panel
-
INGREDIENTS AND APPEARANCE
VITAMIN B COMPLEX 150
vitamin b complex injectionProduct Information Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:59051-9085 Route of Administration INTRAVENOUS, INTRAMUSCULAR Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength THIAMINE HYDROCHLORIDE (UNII: M572600E5P) (THIAMINE ION - UNII:4ABT0J945J) THIAMINE 150 mg in 1 mL RIBOFLAVIN 5'-PHOSPHATE SODIUM (UNII: 20RD1DZH99) (FLAVIN MONONUCLEOTIDE - UNII:7N464URE7E) FLAVIN MONONUCLEOTIDE 2 mg in 1 mL NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE 150 mg in 1 mL PANTHENOL (UNII: WV9CM0O67Z) (PANTHENOL - UNII:WV9CM0O67Z) PANTHENOL 10 mg in 1 mL PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE 10 mg in 1 mL INOSITOL (UNII: 4L6452S749) (INOSITOL - UNII:4L6452S749) INOSITOL 20 mg in 1 mL CHOLINE CHLORIDE (UNII: 45I14D8O27) (CHOLINE - UNII:N91BDP6H0X) CHOLINE 20 mg in 1 mL Inactive Ingredients Ingredient Name Strength BENZYL ALCOHOL (UNII: LKG8494WBH) .02 mL in 1 mL WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:59051-9085-5 100 mL in 1 VIAL, MULTI-DOSE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 09/01/2017 Labeler - Neogen Corporation - Nandino (042125879) Registrant - Neogen Corporation - Nandino (042125879) Establishment Name Address ID/FEI Business Operations Sparhawk Laboratories, Inc. 147979082 analysis, manufacture Establishment Name Address ID/FEI Business Operations Jiangxi Tianxin Pharmaceutical Co., Ltd. 527410270 api manufacture